MiR-122 in hepatic function and liver diseases

Protein and Cell

Volumn 3, Issue 5, 2012, Pages 364-371

  Hu, Jun ^a   Xu, Yaxing ^a   Hao, Junli ^a   Wang, Saifeng ^a   Li, Changfei ^a   Meng, Songdong ^a  

^a INSTITUTE OF MICROBIOLOGY   (China)

Author keywords

hepatitis B virus (HBV); hepatitis C virus (HCV); hepatocellular carcinoma (HCC); lipid metabolism; liver development; miR 122

Indexed keywords

ANTAGOMIR; LOCKED NUCLEIC ACID; MICRORNA 122; MIRAVIRSEN; OLIGONUCLEOTIDE PHOSPHOROTHIOATE; PEGINTERFERON ALPHA; VIRUS RNA;

5' UNTRANSLATED REGION; BINDING SITE; CANCER INHIBITION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; DOWN REGULATION; GENE EXPRESSION; GENE TARGETING; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIPID METABOLISM; LIVER CELL; LIVER CELL CARCINOMA; LIVER DEVELOPMENT; LIVER DISEASE; LIVER FUNCTION; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA STABILITY; VIRUS REPLICATION;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 84861705805     PISSN: 1674800X     EISSN: 16748018     Source Type: Journal    
DOI: 10.1007/s13238-012-2036-3     Document Type: Review

References (59)

1. Bai, S., Nasser, M. W., Wang, B., Hsu, S. H., Datta, J., Kutay, H., Yadav, A., Nuovo, G., Kumar, P., and Ghoshal, K. (2009). MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. J Biol Chem 284, 32015-32027.
2. Belver, L., de Yébenes, V. G., and Ramiro, A. R. (2010). MicroRNAs prevent the generation of autoreactive antibodies. Immunity 33, 713-722.
3. Burchard, J., Zhang, C., Liu, A. M., Poon, R. T., Lee, N. P., Wong, K. F., Sham, P. C., Lam, B. Y., Ferguson, M. D., Tokiwa, G., et al. (2010). microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma. Mol Syst Biol 6, 1-12.
4. Burns, D. M., D'Ambrogio, A., Nottrott, S., and Richter, J. D. (2011). CPEB and two poly (A) polymerases control miR-122 stability and p53 mRNA translation. Nature 473, 105-108.
5. Carissimi, C., Fulci, V., and Macino, G. (2009). MicroRNAs: novel regulators of immunity. Autoimmun Rev 8, 520-524.
6. Chang, J., Guo, J. T., Jiang, D., Guo, H., Taylor, J. M., and Block, T. M. (2008). Liver-specific microRNA miR-122 enhances the replication of hepatitis C virus in nonhepatic cells. J Virol 82, 8215-8223.
7. Chen, S., Ni, M., Yu, B., Lv, T., Lu, M., and Gong, F. (2007). Construction and identification of a human liver specific microRNA eukaryotic expression vector. Cell Mol Immunol 4, 473-477.
8. Chen, Y., Shen, A., Rider, P. J., Yu, Y., Wu, K., Mu, Y., Hao, Q., Liu, Y., Gong, H., Zhu, Y., et al. (2011). A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication. FASEB J 25, 4511-4521.
9. Coulouarn, C., Factor, V. M., Andersen, J. B., Durkin, M. E., and Thorgeirsson, S. S. (2009). Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 28, 3526-3536.
10. Díaz-Toledano, R., Ariza-Mateos, A., Birk, A., Martínez-García, B., and Gómez, J. (2009). In vitro characterization of a miR-122-sensitive double-helical switch element in the 5′ region of hepatitis C virus RNA. Nucleic Acids Res 37, 5498-5510.
11. Elmén, J., Lindow, M., Schütz, S., Lawrence, M., Petri, A., Obad, S., Lindholm, M., Hedtjärn, M., Hansen, H. F., Berger, U., et al. (2008a). LNA-mediated microRNA silencing in non-human primates. Nature 452, 896-899.
12. Elmén, J., Lindow, M., Silahtaroglu, A., Bak, M., Christensen, M., Lind-Thomsen, A., Hedtjärn, M., Hansen, J. B., Hansen, H. F., Straarup, E. M., et al. (2008b). Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res 36, 1153-1162.
13. Esau, C., Davis, S., Murray, S. F., Yu, X. X., Pandey, S. K., Pear, M., Watts, L., Booten, S. L., Graham, M., McKay, R., et al. (2006). miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3, 87-98.
14. Esau, C. C. (2008). Inhibition of microRNA with antisense oligonucleotides. Methods 44, 55-60.
15. Fan, C. G., Wang, C. M., Tian, C., Wang, Y., Li, L., Sun, W. S., Li, R. F., and Liu, Y. G. (2011). miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3. Oncol Rep 26, 1281-1286.
16. Filipowicz, W., and Grosshans, H. (2011). The liver-specific microRNA miR-122: biology and therapeutic potential. Prog Drug Res 67, 221-238.
17. Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., and Mello, C. C. (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811.
18. Fornari, F., Gramantieri, L., Giovannini, C., Veronese, A., Ferracin, M., Sabbioni, S., Calin, G. A., Grazi, G. L., Croce, C. M., Tavolari, S., et al. (2009). MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res 69, 5761-5767.
19. Girard, M., Jacquemin, E., Munnich, A., Lyonnet, S., and Henrion-Caude, A. (2008). miR-122, a paradigm for the role of microRNAs in the liver. J Hepatol 48, 648-656.
20. Henke, J. I., Goergen, D., Zheng, J., Song, Y., Schüttler, C. G., Fehr, C., Jünemann, C., and Niepmann, M. (2008). microRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J 27, 3300-3310.
21. Jangra, R. K., Yi, M., and Lemon, S. M. (2010). Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR-122. J Virol 84, 6615-6625.
22. Jopling, C. L., Yi, M., Lancaster, A. M., Lemon, S. M., and Sarnow, P. (2005). Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309, 1577-1581.
23. Karakatsanis A, Papaconstantinou I, Gazouli M, Lyberopoulou A, Polymeneas G, Voros D. (2011). Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance. Mol Carcinog 27 Dec 2011. doi: 10. 1002/mc. 21864.
24. Kasinski, A. L., and Slack, F. J. (2011). Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 11, 849-864.
25. Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., and Stoffel, M. (2005). Silencing of microRNAs in vivo with 'antagomirs'. Nature 438, 685-689.
26. Kummee, P., Tangkijvanich, P., Poovorawan, Y., and Hirankarn, N. (2007). Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population. J Viral Hepat 14, 841-848.
27. Lanford, R. E., Hildebrandt-Eriksen, E. S., Petri, A., Persson, R., Lindow, M., Munk, M. E., Kauppinen, S., and Ørum, H. (2010). Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327, 198-201.
28. Laudadio, I., Manfroid, I., Achouri, Y., Schmidt, D., Wilson, M. D., Cordi, S., Thorrez, L., Knoops, L., Jacquemin, P., Schuit, F., et al. (2012). A feedback loop between the liver-enriched transcription factor network and miR-122 controls hepatocyte differentiation. Gastroenterology 142, 119-129.
29. Lewis, B. P., Burge, C. B., and Bartel, D. P. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20.
30. Lindsay, M. A. (2008). microRNAs and the immune response. Trends Immunol 29, 343-351.
31. Luo, X., Yang, W., Ye, D. Q., Cui, H., Zhang, Y., Hirankarn, N., Qian, X., Tang, Y., Lau, Y. L., de Vries, N., et al. (2011). A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus. PLoS Genet 7, e1002128.
32. Ma, L., Liu, J., Shen, J., Liu, L., Wu, J., Li, W., Luo, J., Chen, Q., and Qian, C. (2010). Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells. Cancer Biol Therapy 9, 554-561.
33. Miyoshi, K., Okada, T. N., Siomi, H., and Siomi, M. C. (2009). Characterization of the miRNA-RISC loading complex and miRNA-RISC formed in the Drosophila miRNA pathway. RNA 15, 1282-1291.
34. Mizuguchi, Y., Mishima, T., Yokomuro, S., Arima, Y., Kawahigashi, Y., Shigehara, K., Kanda, T., Yoshida, H., Uchida, E., Tajiri, T., et al. (2011). Sequencing and bioinformatics-based analyses of the microRNA transcriptome in hepatitis B-related hepatocellular carcinoma. PLoS One 6, e15304.
35. Moore, K. J., Rayner, K. J., Suárez, Y., and Fernández-Hernando, C. (2010). microRNAs and cholesterol metabolism. Trends Endocrinol Metab 21, 699-706.
36. Morita, K., Taketomi, A., Shirabe, K., Umeda, K., Kayashima, H., Ninomiya, M., Uchiyama, H., Soejima, Y., and Maehara, Y. (2011). Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C. Liver Int 31, 474-484.
37. Murchison, E. P., Stein, P., Xuan, Z., Pan, H., Zhang, M. Q., Schultz, R. M., and Hannon, G. J. (2007). Critical roles for Dicer in the female germline. Genes Dev 21, 682-693.
38. Narbus, C. M., Israelow, B., Sourisseau, M., Michta, M. L., Hopcraft, S. E., Zeiner, G. M., and Evans, M. J. (2011). HepG2 cells expressing microRNA miR-122 support the entire hepatitis C virus life cycle. J Virol 85, 12087-12092.
39. Newman, M. A., and Hammond, S. M. (2010). Emerging paradigms of regulated microRNA processing. Genes Dev 24, 1086-1092.
40. Norman, K. L., and Sarnow, P. (2010). Modulation of hepatitis C virus RNA abundance and the isoprenoid biosynthesis pathway by microRNA miR-122 involves distinct mechanisms. J Virol 84, 666-670.
41. Pang, P. S., Pham, E. A., Elazar, M., Patel, S. G., Eckart, M. R., and Glenn, J. S. (2012). Structural map of a Pan PS, microRNA-122: Hepatitis C virus complex. J Virol 86, 1250-1254.
42. Pedersen, I. M., Cheng, G., Wieland, S., Volinia, S., Croce, C. M., Chisari, F. V., and David, M. (2007). Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 449, 919-922.
43. Ramezani, A., Hasanjani Roshan, M. R., Kalantar, E., Eslamifar, A., Banifazl, M., Taeb, J., Aghakhani, A., Gachkar, L., and Velayati, A. A. (2008). Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection. J Gastroenterol Hepatol 23, 1716-1721.
44. Reinhart, B. J., Slack, F. J., Basson, M., Pasquinelli, A. E., Bettinger, J. C., Rougvie, A. E., Horvitz, H. R., and Ruvkun, G. (2000). The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403, 901-906.
45. Rusca, N., and Monticelli, S. (2011). MiR-146a in Immunity and Disease. Mol Biol Int 2011, 437301.
46. Sage, J., Ventura, A., and Macino, G. (2011). miR than meets the eye. Genes Dev 25, 1663-1667.
47. Sarasin-Filipowicz, M., Krol, J., Markiewicz, I., Heim, M. H., and Filipowicz, W. (2009). Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat Med 15, 31-33.
48. Shan, Y., Zheng, J., Lambrecht, R. W., and Bonkovsky, H. L. (2007). Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes. Gastroenterology 133, 1166-1174.
49. Shimakami, T., Yamane, D., Jangra, R. K., Kempf, B. J., Spaniel, C., Barton, D. J., and Lemon, S. M. (2012). Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex. Proc Natl Acad Sci U S A 109, 941-946.
50. Starczynowski, D. T., Kuchenbauer, F., Argiropoulos, B., Sung, S., Morin, R., Muranyi, A., Hirst, M., Hogge, D., Marra, M., Wells, R. A., et al. (2010). Identification of miR-145 and miR-146a as mediators of the 5q-syndrome phenotype. Nat Med 16, 49-58.
51. Tan, A. T., Loggi, E., Boni, C., Chia, A., Gehring, A. J., Sastry, K. S., Goh, V., Fisicaro, P., Andreone, P., Brander, C., et al. (2008). Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire. J Virol 82, 10986-10997.
52. Wang S, Qiu L, Yan X, Jin W, Wang Y, Chen L, Wu E, Ye X, Gao GF, Wang F, Chen Y, Duan Z, Meng S. (2012). Loss of MiR-122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G1 modulated P53 activity. Hepatology 23 Feb 2012. doi: 10. 1002/hep. 24809.
53. Xu, H., He, J. H., Xiao, Z. D., Zhang, Q. Q., Chen, Y. Q., Zhou, H., and Qu, L. H. (2010). Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development. Hepatology 52, 1431-1442.
54. Xu, J., Zhu, X., et al. (2012). MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/beta-catenin pathway. Liver Int 26 Jan 2012. doi: 10. 1111/j. 1478-3231. 2011. 02750. x.
55. Xu, Y., Xia, F., Ma, L., Shan, J., Shen, J., Yang, Z., Liu, J., Cui, Y., Bian, X., Bie, P., et al. (2011). MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest. Cancer Lett 310, 160-169.
56. Yang, F., Zhang, L., Wang, F., Wang, Y., Huo, X. S., Yin, Y. X., Wang, Y. Q., Zhang, L., and Sun, S. H. (2011). Modulation of the unfolded protein response is the core of microRNA-122-involved sensitivity to chemotherapy in hepatocellular carcinoma. Neoplasia 13, 590-600.
57. Zeng, C., Wang, R., Li, D., Lin, X. J., Wei, Q. K., Yuan, Y., Wang, Q., Chen, W., and Zhuang, S. M. (2010). A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma. Hepatology 52, 1702-1712.
58. Zhang, L., Zhang, B., Valdez, J. M., Wang, F., Ittmann, M., and Xin, L. (2010). Dicer ablation impairs prostate stem cell activity and causes prostate atrophy. Stem Cells 28, 1260-1269.
59. Zhou, X., Jeker, L. T., Fife, B. T., Zhu, S., Anderson, M. S., McManus, M. T., and Bluestone, J. A. (2008). Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J Exp Med 205, 1983-1991.